amgen maritide glp-1 drug comparison A GIPR antagonist conjugated to analogues promotes weight loss with improved metabolic parameters in preclinical and phase 1 settings Amgen's obesity drug may help
Pay in 4 interest-free payments of $6.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
























